Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Agreement Between Time-Domain and Spectral-Domain Optical Coherence Tomography in the Assessment of Macular Thickness in Patients with Idiopathic Macular Telangiectasia Type 2

Go back to Resources

Agreement Between Time-Domain and Spectral-Domain Optical Coherence Tomography in the Assessment of Macular Thickness in Patients with Idiopathic Macular Telangiectasia Type 2

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy

Go back to Resources

A Phase 1 Study of Heat/Phenol-Killed, E. coli - Encapsulated, Recombinant Modified Peanut Proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the Treatment of Peanut Allergy

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Transitioning Paper to Electronic Case Report Forms Mid-Study From One Clinical Research Organization to Another

Go back to Resources

Transitioning Paper to Electronic Case Report Forms Mid-Study From One Clinical Research Organization to Another

Authors:

Secondary:

Location:

URL:

Keywords:

Go back to Resources

Tracking of regulatory documents in a large clinical trial, The Age-Related Eye Disease Study 2

Go back to Resources

Tracking of regulatory documents in a large clinical trial, The Age-Related Eye Disease Study 2

Authors:

Secondary:

Location:

URL:

Go back to Resources

Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial

Go back to Resources

Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration

Go back to Resources

Spectral-Domain Optical Coherence Tomography Characteristics of Intermediate Age-Related Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

SCORE Study Report 12: Development of Venous Collaterals in the SCORE Study

Go back to Resources

SCORE Study Report 12: Development of Venous Collaterals in the SCORE Study

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Response to Therapy Following Retreatment of Serofast Early Syphilis Patients with Benzathine Penicillin

Go back to Resources

Response to Therapy Following Retreatment of Serofast Early Syphilis Patients with Benzathine Penicillin

Authors:

Secondary:

Volume:

Pagination:

URL:

Abstract:

Go back to Resources

Response to Commentaries

Go back to Resources

Response to Commentaries

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Go back to Resources

Randomized, Placebo-Controlled, Multicenter Trial of Egg Oral Immunotherapy in Children: An Analysis of Clinical Tolerance

Go back to Resources

Randomized, Placebo-Controlled, Multicenter Trial of Egg Oral Immunotherapy in Children: An Analysis of Clinical Tolerance

Authors:

Secondary:

Volume:

Pagination:

Location:

Publisher:

URL:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • Current page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification